Latest Europe News

Bindi Metals has appointed seasoned executive Mark Freeman as CEO, aiming to leverage his extensive resource sector experience to advance its exploration projects across three continents.

Evion Group has landed a significant A$1.5 million order to supply expandable graphite to a major US graphite supply chain company, reinforcing its position as a trusted non-Chinese supplier amid growing demand.

EML Payments has appointed Stuart Will as its new Chief Financial Officer, marking a key leadership transition as the company advances its growth strategy. The change follows significant financial restructuring under outgoing CFO James Georgeson.

Mont Royal Resources has restarted key flotation test work on its Ashram Rare Earth Elements and Fluorspar Project, aiming to refine processing flowsheets and explore fluorspar by-product potential.

IMDEX has announced the acquisition of Advanced Logic Technology (ALT) and Mount Sopris Instruments (MSI), broadening its portfolio in downhole sensing and geoscience software with expected earnings accretion in FY26.

Variscan Mines Limited is advancing its high-grade zinc projects in Spain with a near-term production target and strategic expansion into Ireland, supported by strong drilling results and favorable market conditions.

South Harz Potash Limited (SHP) has secured an option to acquire the Glava copper-gold project in Sweden, complementing its advanced potash development in Germany and reinforcing its multi-commodity European strategy.

Urenco Limited has secured Foreign Investment Review Board approval for its strategic investment in Ubaryon, where Global Uranium and Enrichment Limited holds a significant stake, marking a key milestone in advancing innovative uranium enrichment technology.

European Metals Holdings has been awarded a substantial grant of up to €360 million by the Czech Government to advance its Cinovec Lithium Project, underscoring the project's strategic importance in Europe's clean energy transition.

Metallium Ltd has revealed significant progress in commercialising its Flash Joule Heating technology with a new Texas facility and key partnerships, setting the stage for global expansion in critical metals recovery.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.